Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Annals of the Rheumatic Diseases (ARD)
Published October 29, 2026
Practical recommendations for revaccination following BCMA-targeted therapies in adult patients w...
October 30, 2026
Medspoke
Medspoke
Annals of the Rheumatic Diseases (ARD)
Published October 29, 2026
00:00
--:--
Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study.
October 30, 2026
Share
Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study.
https://www.medspoke.co/channel_journal?id=688&tap_id=16722
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Rheumatology (Oxford)
Published October 29, 2026
Serological and clinical outcomes of rituximab in antiphospholipid syndrome with or without SLE: ...
October 30, 2026
Why are you reporting this TALK?
